NHS BARNSLEY. Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House.
|
|
- Amberly Flynn
- 5 years ago
- Views:
Transcription
1 Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday 13 th February 2013 in the Boardroom at Hillder House. PRESENT: Dr M Ghani (Chair) Medical Director Barnsley CCG (Designate) Dr M Al-Bazzaz Consultant in Elderly Medicine (BHNFT) (items 13/13.6 onwards) Mr T Bisset Community Pharmacist (LPC) Mrs S Hudson Lead Pharmacist (SWYPFT) (items 13/12 to 13/15.2 and item 13/21.3) Dr P Jha Consultant Physician General & Geriatric Medicine (SWYPFT) (items 13/13.6 to 13/15.2 and item 13/21.3) Dr J Maters General Practitioner (items 13/13.5 onwards) Mr M Smith Chief Pharmacist (BHNFT) Ms D Cooke Lead Pharmacist (NHS Barnsley) IN ATTENDANCE: Ms C Applebee Ms G Smith APOLOGIES: Dr R Hirst Dr S Chari Ms L Haygarth Dr K Kapur Dr K Sands Mrs C Lawson Dr Munzar Prescribing Support Pharmacist (NHS Barnsley) Medicines Information Pharmacist (BHNFT) Palliative Care Consultant (Barnsley Hospice) Associate Medical Director (SWYPFT) Chief Pharmacist (SWYPFT) Consultant Gastroenterologist (BHNFT) Associate Medical Director (SWYPFT) Head of Medicines Management (NHS Barnsley) General Practitioner APC 13/12 MINUTES OF PREVIOUS MEETING The minutes of the meeting held on 9 th January 2013 were agreed as a correct record. ACTION APC 13/13 MATTERS ARISING 13.1 Omacor Post MI Caron Applebee presented the academic detail aid for the prescribing of omega-3 supplements which had been updated to incorporate the changes discussed at previous APC meetings (items 12/112.1 and 12/122.1). The updated document had been approved by the Cardiologists. The guidance was endorsed by the Committee and it was agreed that the guidance would be circulated with the APC memo. DC 13.2 D1s Mike Smith explained that BHNFT had been undertaking a significant amount of work around D1s. The acute trust had recently received authorisation to access primary care records through the Summary Care Records and would be working with the SHA to facilitate this. Pharmacy will be one of the first areas where
2 this initiative is rolled out. NHS BARNSLEY BHNFT is also in the process of producing an SOP and booklet for prescribers on how to complete electronic D1s. Mike Smith confirmed that medicines management was also back on the junior doctors induction programme. Dr Ghani explained that the CCG was looking at introducing a CQUIN into the acute trust contract from around the quality of information on D1s. The CCG has also approved funding for a new IT system for D1s. Dr Ghani explained that part of the CQUIN may involve freeing up ward pharmacists to allow them to spend more time with the patient and less time completing administrative tasks. Mike Smith confirmed that this fitted in with the Pharmacy Transformation Programme and that in automation will be introduced into the dispensing process for inpatients which will also free up pharmacist time. Tom Bisset explained that a number of pharmacies did not currently have nhs.net accounts and were therefore unable to receive discharge information electronically. It was highlighted that pharmacies were unable to choose their own domain names which has caused issues for some of the larger pharmacy chains. Gillian Smith confirmed that she would follow up the suggestion raised in the last meeting relating to pharmacists ensuring that shared care arrangements were in place for shared care drugs started during hospital admission. The Committee discussed ways in which shared care drugs could be highlighted on the D1. Gillian Smith suggested adding this information to the drug selection drop down box on the system and agreed to take this to the next Pharmacy Operations Group. It was noted that there had been a slight delay in setting up the Interface Group and that Richard Sykes would be organising this in the near future. Richard Sykes 13.3 DMARD Shared Care Guideline Caron Applebee presented the guideline which had been updated to incorporate the changes discussed at the previous meeting. The updated shared care guideline was approved by the Committee subject to ratification by the LMC. It was agreed that the tick box to confirm whether the shared care request had been accepted or rejected by the GP would be included in all future shared care guidelines Retigabine Shared Care Guideline Gillian Smith presented the shared care guideline. It was noted that the guideline had not yet been agreed by secondary care consultants and could therefore not be approved as a shared care guideline at this current time. It was noted that the information
3 regarding the quantity to be supplied by the initiating prescriber should be consistent throughout the document. The Committee agreed that the guideline would serve as an information resource to support GPs who were asked to prescribe retigabine by hospitals outside of the local area in the interim until the shared care guideline could be approved in its entirety Vitamin D Prescribing Guidance Gillian Smith informed the Committee that regular calcium monitoring was recommended for pregnant women receiving treatment doses of vitamin D (4000 units daily). Gillian Smith agreed to update the guideline in consultation with the Obstetricians. It was also noted that the vitamin D guidance was due to be updated in March 2013 and Gillian Smith agreed to liaise with Dr Jha regarding the update. It was highlighted that different consultants used different dosing regimes and it was agreed that the updated guideline would contain information on the various drugs and doses used locally. A discussion followed regarding whether patients should be advised to purchase high dose vitamin D over the counter or if this should be prescribed. Although there was a difference in opinion amongst Committee members the majority view was that patients could be encouraged to purchase the lower doses but treatment doses should be prescribed. Dr Jha informed the Committee that NICE vitamin D guidance was due to be published in May 2013 and it was agreed that the local guideline would be reviewed in a few months time when the NICE guidance was available Esomeprazole and Gaviscon Advance prescribing by ENT Committee members confirmed that this was still an ongoing issue and that requests to prescribe were also coming from Speech and Language Therapy as well as from ENT. Sarah Hudson agreed to follow up with Deborah McCloud, Speech and Language Therapy Service Manager. Gillian Smith confirmed that there had been little prescribing of esomeprazole by ENT in the acute trust. It was noted that ENT appeared to be bypassing the hospital pharmacy and asking GPs to prescribe both esomeprazole and Gaviscon Advance. Gillian Smith confirmed that ENT had been informed that Gaviscon Advance wasn t on the formulary on a number of previous occasions. It was agreed that this should now be escalated to the acute trust Medical Director and Gillian Smith agreed to pursue SH
4 this Stroke prevention in AF Dr Jha fed back on a review he had been involved with in a local GP practice. Mike Smith explained that the anticoagulant clinic within BHNFT had experienced a significant increase in the number of referrals as a result of the GRASP-AF work being undertaken in primary care which was causing capacity issues. Dr Ghani informed the Committee that an AF review local enhanced service was in the process of being introduced in primary care. Training will be provided for practices signing up to this to enable them to prescribe in accordance with the NORCOM guidance and minimise the number of secondary care referrals. Mike Smith asked if the practices delivering the existing anticoagulant service would be authorised to initiate warfarin. Deborah Cooke agreed to find out how many practices were signed up to the existing anticoagulation local enhanced service and how many of these could initiate warfarin and feedback to Mike Smith. DC Dr Jha queried if patients with a CHADS2 score of 1 would be reviewed as part of this work. Dr Ghani confirmed that practices would be advised to review patients with a CHADS2 score of 1 and above who were not prescribed anticoagulants. Mike Smith confirmed that the anticoagulant clinic followed the NORCOM guidance in response to a query raised. Tom Bisset requested that a letter was sent to community pharmacists to inform them of the expected increase in patients commencing anticoagulants over the coming months. DC/CL 13.8 Management of depression in Primary Care The guidance which had been updated in light of comments received at the previous meeting was accepted by the Committee. Sarah Hudson confirmed that she had compared the SWYFT guidance against the drugs on the Barnsley antidepressant formulary and a few differences were noted. Dosulepin was still included on the Barnsley formulary but was no longer recommended. Imipramine which had been included as a second line option for severe depression in the SWYFT guidance was in the Barnsley formulary for enuresis but not depression and paroxetine was included in the Barnsley formulary but was not recommended for the treatment of depression in the SWYFT guideline. Following a query Sarah Hudson confirmed that whilst
5 paroxetine would no longer be initiated for depression in new patients, there was no need to switch treatment in patients currently stabilised on this. It was agreed that agomelatine, phenelzine and mianserin would remain non formulary and would be available on consultant request. Gillian Smith agreed to update the formulary with the above information. It was agreed that the dosulepin entry would be updated with the advice that it should no longer be initiated in new patients. 13/14 New Product Applications The updated new product application log was noted. Gillian Smith confirmed that she was awaiting feedback from the consultants on the dry eye guidelines and confirmed that this would be brought to the March meeting Consillient Health Oral Contraceptives Caron Applebee presented the new product application and supporting information. It was noted that the preparations were equivalent to existing contraceptive brands but cost approximately 30% less. Sarah Hudson confirmed that these brands were currently being used within the SH team. It was agreed that Rigevidon, Gedarel 30/150, Gedarel 20/150, Millinette 30/75, Millinette 20/75 and Cerelle would be added to the formulary with a green classification. / 14.2 Perampanel Gillian Smith presented the new product application and supporting evidence and confirmed that she would bring the signed application to the next meeting. Following a discussion of the evidence and place in therapy it was agreed that perampanel would be approved with a red classification. Gillian Smith agreed to feed this back to Dr Grunewald and informed the Committee that she was intending to produce an algorithm outlining the place in therapy of this and other anticonvulsants used for refractory epilepsy. 13/15 Shared Care Guidelines 15.1 Quetiapine shared care guideline Sarah Hudson presented the updated shared care guideline. It was agreed that a section to confirm whether the GP accepted or rejected the shared care agreement would be added to the proforma. The shared care guideline was approved by the Committee subject to ratification by the LMC.
6 Sarah Hudson confirmed that SWYFT were advising prescribers to use standard release quetiapine in new patients and reserving the XL preparation for patients currently stabilised on it. Dr Maters queried whether patients could be switched to the standard release preparation when doses were increased. Sarah Hudson agreed to clarify this with the consultants. SH 15.2 Risperidone shared care guideline The shared care guideline was approved by the Committee subject to ratification by the LMC. It was agreed that a section to confirm whether the GP accepted or rejected the shared care agreement would be added to the form. 13/16 Primary Care Antimicrobial prescribing guidelines Caron Applebee presented the updated guidance to the Committee which included guidance on urinary tract infections produced by Dr Pang. The Committee approved the updated guidance and it was agreed that this would be taken to the next LMC meeting. 13/17 Newer oral anticoagulant guidance (NORCOM) It was noted that the Clinical Advisory Group had confirmed that clinicians could exercise their clinical judgement when prescribing the newer oral anticoagulants and prescribe dabigatran if considered clinically appropriate. 13/18 Feedback on opioid prescribing audit at BHNFT Gillian Smith informed the Committee that the percentage of fentanyl and buprenorphine patches from all strong opioids prescribed in the acute trust was 25% and 35% respectively. Gillian Smith confirmed that work was ongoing in this area of prescribing within BHNFT as part of the Transformation Programme. This will include the production of guidance on the prescribing of strong opioids and the promotion of oral morphine (Zomorph ) as the first line strong opioid of choice. 13/19 Feedback on diclofenac audit at BHNFT Gillian Smith confirmed that diclofenac use within BHNFT had reduced by 15% since the NSAID guidance had been circulated. Orthopaedics were still prescribing significant quantities of diclofenac and Gynaecology was highlighted as another area where diclofenac was still used. Gillian Smith agreed to approach both of these clinical areas and escalate to the Medical Director if necessary.
7 13/20 NICE guidance summary December 2012 and January 2013 Deborah Cooke reminded the Committee that all organisations were required to include all drugs which had received a positive NICE Technology Appraisal in local formularies by the 1st April 2013, if the drug was clinically appropriate and relevant to the services provided by the organisation. The summary of NICE guidance produced in December and January was considered by the Committee. Mike Smith informed the Committee that the BHNFT Clinical and Guidelines and Policy Group currently considered all new NICE TAs and agreed to share this information with the APC in future meetings. It was agreed that Sarah Hudson would be asked about the process for considering new NICE TAs within SWYFT and if this information could also be brought to the Committee. It was noted that NICE advised that new NICE TAs were included as a standing agenda item on formulary decision making groups. The Committee agreed that NICE TAs and feedback from the relevant groups would be included as a standing agenda item in future meetings. MS DC/SH DC 13/21 FEEDBACK FROM THE MEDICINES MANAGEMENT GROUPS ACTIONS TO DATE IN ADDITION TO PLANNED FUTURE ACTIONS:- Quality & Cost Effective Prescribing Group NHS Barnsley The Group were due to meet later this month. Medicines Management Committee BHNFT No actions to report Drug and Therapeutics Committee SYWPFT (considered after item 13/16.2) The contents of the newsletter were noted. Tom Bisset fed back on an issue he had encountered when prescriptions had been left in patients homes by the Memory Team and the relative/carer had not been informed which had resulted in a delay in the prescription(s) reaching the pharmacy. In response to a query, Sarah Hudson confirmed that aripiprazole should not be used first line but should be reserved for patients who were unable to tolerate other antipsychotics.
8 13/22 feedback A MHS consultant had informed the Committee that a small number of practices were not accepting shared care requests for ADHD drugs. Deborah Cooke confirmed that the Medicines Management Team were in the process of following up with the practices involved. 13/23 MHRA DRUG SAFETY UPDATE JANUARY 2013 The Drug Safety Update was noted for information. 13/24 NEW PRODUCT BULLETIN JANUARY AND FEBRUARY 2013 The bulletin for January and February 2013 was received and noted. Members considered the items and awarded a provisional traffic light status subject to a new product application as follows:- New Formulations Saxagliptin plus metformin 2.5/850mg and 2.5/1000mg (Komboglyze ) provisional grey Estradiol 1.5mg plus Nomegestrol 2.5mg (Zoely ) provisional grey The SPC change for Fostair was noted and it was suggested that its position on the formulary should be reviewed in the near future. 13/25 SOUTH YORKSHIRE APC MINUTES Doncaster and Bassetlaw APC - November 2012 The minutes from Doncaster and Bassetlaw APC for the September meeting were noted for information. 13/26 ANY OTHER BUSINESS 26.1 Neurologists prescribing Alzheimer s Drugs Dr Ghani referred to a request from the Neurologists to prescribe Alzheimer s Drugs without a shared care agreement being in place and before patients had been referred to the Memory Service. It was agreed that the prescribing should remain with the initiating specialist until the patient had been reviewed by the Memory Team. Gillian Smith agreed to feed this back Declarations of interest Dr Ghani explained that Committee members would need to start signing a declaration of interest form and it was agreed that this would be included as a standing agenda item from April. DC Date and Time of Next Meeting Wednesday 13 th Hillder House. March 2013 at pm, Boardroom left,
Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday, 11 th October 2017 in the Boardroom, Hillder House
Minutes of the meeting of the AREA PRESCRIBING COMMITTEE held on Wednesday, 11 th October 2017 in the Boardroom, Hillder House MEMBERS: Dr M Ghani (Chair) Mr T Bisset Dr R Hirst (left after 17/190.1) Ms
More informationDONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August NHS Doncaster CCG RDaSH FT Doncaster LPC
Present: DONCASTER and BASSETLAW AREA PRESCRIBING COMMITTEE MINUTES from Thursday 27 th August 2015 NHS Doncaster CCG RDaSH FT Doncaster LPC Dr Rumit Shah ( APC Chair) Mr Mark Randerson- Head of Medicines
More informationMedicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationClinical Commissioning Group
Clinical Commissioning Group Title of Meeting: Time: NHS Rotherham Medicines Management Committee Meeting 9.00am 11.00am Date: Wednesday 8 th October 2017 Venue: Reference: Chair: Cedar Room G.02 Oak House
More informationSouth East London Area Prescribing Committee (APC) 9 October at Lower Marsh. Final minutes
South East London Area Prescribing Committee (APC) 9 October at Lower Marsh Final minutes 1. Welcome, Introductions and Apologies received. 2. Conflicts of Interest declarations The Chair requested any
More informationTo contact us please
Issue 13, June 2015 Newsletter for Care Home staff, General Practitioners and Community Pharmacists The Caring for Care Homes team produced The Medicines Management Checklist in 2010 to provide care homes
More informationPutting Barnsley People First. Quality and Patient Safety Committee Terms of Reference
Putting Barnsley People First Quality and Patient Safety Committee Terms of Reference 1. Introduction NHS Barnsley Clinical Commissioning Group Quality and Patient Safety Committee 1.1 The Clinical Commissioning
More informationPrescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services
Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing
More informationAll Wales Multidisciplinary Medicines Reconciliation Policy
All Wales Multidisciplinary Medicines Reconciliation Policy June 2017 This document has been prepared by the Quality and Patient Safety Delivery Group of the All Wales Chief Pharmacists Group, with support
More informationPOWYS TEACHING HEALTH BOARD PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE
POWYS TEACHING HEALTH BOARD Meeting 04/12/12 Present: PRIMARY CARE PRESCRIBING AND THERAPEUTICS COMMITTEE Minutes of the meeting held on Thursday, 06 September 2012 at 09.30am in Training Room 1, Bronllys
More informationPatient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019
THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire
More informationMINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING
MINUTES OF THE MEDICINES MANAGEMENT GROUP MEETING Date & Time of Meeting: Venue: Wednesday 8 th February 2012 @ 1.30pm Boardroom, Glangwili Hospital, Carmarthen Present: In Attendance: Dr. Carol Llewellyn-Jones,
More informationSouth East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
More informationPRESCRIBING SUPPORT TECHNICIAN:
PRESCRIBING SUPPORT TEAM AUDIT: CARDURA XL (Updated Sept 09) DATE OF AUTHORISATION: AUTHORISING GP: PRESCRIBING SUPPORT TECHNICIAN: SUMMARY Cardura XL is a once daily, extended release preparation of doxazosin
More informationAnti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
More informationANTI-COAGULATION MONITORING
ANTI-COAGULATION MONITORING 2016-17 a) Purpose of Agreement This Agreement outlines the service to be provided by the Provider, called an Anti-coagulation monitoring service. b) Duration of Agreement This
More informationInformation shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
More informationProcedure to Allow Nursing Staff to Dispense Leave and Discharge Medication
Procedure to Allow Nursing Staff to Dispense Leave and Discharge Medication Version 2 minor update June 2013 Procedure Number Replaces Policy No. Ratifying Committee N/a PPPF Date Ratified April 2009 Minor
More informationPharmacy Medicine Use Review What s it all about?
Pharmacy Medicine Use Review What s it all about? 1. What is it? 1.1 Medicine use Review has been introduced under the Advanced Services tier of the New Pharmacy Contract in England & Wales. The aim of
More informationOxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients
Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie
More informationSouth East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions
South East London Area Prescribing Committee (APC) 13 October 2016 at Lower Marsh Approved minutes 1. Welcome, and Introductions 2. Conflicts of Interest declarations The Chair requested any interests,
More informationNew v1.0 Date: Cathy Riley - Director of Pharmacy Policy and Procedures Committee Policy and Procedures Committee
Clinical Pharmacy Services: SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key Words:
More informationMMPR034 MEDICINES RECONCILIATION ON ADMISSION TO HOSPITAL PROTOCOL
MMPR034 MEDICINES RECONCILIATION ON ADMISSION TO HOSPITAL PROTOCOL 1 Table of Contents Why we need this Protocol...3 What the Protocol is trying to do...3 Which stakeholders have been involved in the creation
More informationWolverhampton CCG Commissioning Intentions
Wolverhampton CCG Commissioning Intentions 2015-16 * Areas of particular focus and priority CI Ref Contract Provider Brief CI001 CI002 CI003 Child Protection Information Sharing Implement the new Child
More informationApologies for absence were noted from Ms Claire Dobson, Dr I Gourley, Dr J Kennedy, Professor S McLean, Mr I Mohammed.
CONFIRMED MINUTES OF THE MEETING OF THE FIFE DRUGS AND THERAPEUTICS COMMITTEE HELD AT 12.30PM ON WEDNESDAY 4 OCTOBER 2017 IN MEETING ROOM 2, WARD 6, VICTORIA HOSPITAL, KIRKCALDY. Present: Dr Frances Elliot
More informationThoracic surgery medicines
Addressograph Name: Date of birth: Hosp No: NHS No: Thoracic surgery medicines A patient s guide Medicine name Date last dose to be taken 1 Introduction This booklet is for patients waiting to have thoracic
More informationClinical pharmacists in general practice links with community pharmacy
Introduction Pharmacists employed in the GP clinical pharmacist NHS England programme are encouraged to complete online activity recording. One of the activities records how they are working with community.
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
More informationCCG authorisation: the role of medicines management
May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets
More informationLithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations. Version No 2.2.
Livewell Southwest Lithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations Version No 2.2 Review: May 2019 Notice to staff using a paper copy of this guidance
More informationHospital Pharmacy Transformation Plan
Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &
More informationBest Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland. patient CMP
Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland patient CMP nurse doctor For further information relating to Nurse Prescribing please contact the Nurse
More informationImplementing QIPP in care homes Hounslow PCT approach - Delivering positive clinical and cost effective outcomes
Implementing QIPP in care homes Hounslow PCT approach - Delivering positive clinical and cost effective outcomes Unoma Okoli Care Home Pharmacist, Hillingdon PCT unoma.okoli@nhs.net Background CHUMS-Care
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 10. Date of Meeting: 31 st August 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 10 Date of Meeting: 31 st August 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationCPS response to NHS England Items Which Should Not Be Routinely Prescribed: A Consultation on Guidance for CCGs
Prescribed: A Consultation on Guidance Prepared by: Amanda Rae Head of Policy & Development amanda.rae@cps.scot Who are Community Pharmacy Scotland (CPS) & what do they do? Who we are We are the organisation
More informationSwitch protocol: Brands to generic equivalent
Switch protocol: Brands to generic equivalent Applies to HaRD CCG employed Pharmacists and Medicines Optimisation Technicians. These protocols are produced by the NY&AWC MM team hosted by HaRD CCG for
More informationGuidance on the Supply by Pharmacists in Retail Pharmacy Businesses of Medicines to Patients in Residential Care Settings/Nursing Homes
Guidance on the Supply by Pharmacists in Retail Pharmacy Businesses of Medicines to Patients in Residential Care Settings/Nursing Homes Pharmaceutical Society of Ireland Version 4 March 2018 Updates made
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationIs Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better?
Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Vanessa Burgess, Assistant Director, Medicines & LTCs, NHS Lambeth Clinical Commissioning Group;
More informationReconciliation of Medicines on Admission to Hospital
Reconciliation of Medicines on Admission to Hospital Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For
More informationWOLVERHAMPTON CCG. Governing Body Meeting 8 April 2014
WOLVERHAMPTON CCG Governing Body Meeting ` Agenda item:12 TITLE OF REPORT: REPORT PRESENTED BY: Commissioning Committee Summary Dr Kamran Ahmed Title of Report: Update from the Commissioning Committee
More informationClinical Commissioning Group
Clinical Commissioning Group Title of Meeting: NHSR Medicines Management Committee Meeting Time: 9.00am to 11.00am Date: Wednesday 26 October 2016 Venue: Cedar Room, Oak House Reference: AG/JAA Chairman:
More informationUncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE. SECTION 9(a) UNLICENSED MEDICINES
Uncontrolled when printed NHS AYRSHIRE & ARRAN CODE OF PRACTICE FOR MEDICINES GOVERNANCE SECTION 9(a) UNLICENSED MEDICINES BACKGROUND and PURPOSE Under the Medicines Act 1968 (EEC Directive 65/65), a company
More informationPrinciples of Shared Care Protocols
Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the
More informationSetting up the NOAC Service & Taking it to Primary Care
Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationMEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationClinical Commissioning Group
Clinical Commissioning Group Title of Meeting: NHSR Medicines Management Committee Meeting Time: 9.00am to 11.00am Date: Wednesday 26 April 2017 Venue: 2.08, Oak House Reference: NR/DM Chair: Ravi Nalliagounder
More informationThis SLA covers an enhanced service for care homes for older people and not any other care category of home.
Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service
More informationVenue: Salford St James House Present: Name Designation Organisation CCG members
GREATER MANCHESTER MEDICINES MANAGEMENT GROUP Minutes Date: Thursday 16 th February 2017 Time: 1pm 3pm Venue: Salford St James House Present: Name Designation Organisation CCG members Dr Helen Burgess
More informationNHS Fife. Patient Group Direction for Named Community Pharmacists to Supply
Patient Group Direction for Named Community Pharmacists to Supply Senna tablets 7.5mg or Senna syrup 7.5mg/5ml (Total sennosides calculated as sennoside B) For patients aged 16 years and older prescribed
More informationTitle: Replacement of the Commissioning Advisory Forum Agenda Item: 9
Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose
More informationNPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
More informationREQUIREMENT. Identify a minimum of 4 theme areas which are considered to have caused concern for patients during 2012/13
2012/13 SSOTP CQUIN INDICATOR TARGETS INDICATOR REQUIREMENT 1. Patient Experience Milestone 1 (15th working day of April 2012) Identify a minimum of 4 theme areas which are considered to have caused concern
More informationReport to the Trust Board
Report to the Trust Board Southport & Ormskirk Hospital NHS Trust Date of Board Meeting 26 January 2011 AGENDA ITEM: 7c Title of Report EXECUTIVE SUMMARY of the REPORT (please outline the purpose of this
More informationPharmacist (Palliative Care) December 2014 Page 1
Job Profile Job Title: Department: Main Location: Hospice Palliative Care Pharmacist 7 NHS (8SRC) Less than full time(0.8) Full time equivalent around 36,300 Head of Clinical Services 1. Main Purpose of
More informationClinical. Prescribing Medicines SOP. Document Control Summary. Contents
Clinical Prescribing Medicines SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key
More informationLinda Cutter / Dr Charles Heatley. GP Practices and Community Pharmacies
Schedule 2 Part A Service Specification Service Specification No. 04 Service Anti-coagulation Monitoring Levels 3, 4 & 5 Commissioner Lead Provider Lead Linda Cutter / Dr Charles Heatley GP Practices and
More informationTransfer of Care (ToC) service Frequently asked questions
Transfer of Care (ToC) service Frequently asked questions 1) What is the Transfer of Care Service? The Transfer of Care service is a new service which aims to ensure patients receive appropriate support
More informationMs Lyndsey Hands, Graduate Trainee (observer) Mrs Sandra MacDonald (minutes) ACTION
CONFIRMED MINUTES OF THE MEETING OF THE FIFE DRUGS AND THERAPEUTICS COMMITTEE HELD AT 12.30PM ON WEDNESDAY 16 AUGUST 2017 IN MEETING ROOM 2, WARD 6, VICTORIA HOSPITAL, KIRKCALDY. Present: Mrs Evelyn McPhail
More informationReducing Medication Errors: National Update
Reducing Medication Errors: National Update Ahmed Ameer Medication Safety Officer Ahmed.Ameer@NHS.net Safer Medication Practice & Medical Devices Team 27 th January 2015 Agenda 1. Development of the National
More informationPrescribing Advisor for BHR CCGs, representing Barking & Dagenham (B&D) CCG Prescribing Advisor for BHR CCGs, representing Redbridge CCG
BHR CCGs AREA PRESCRIBING SUB-COMMITTEES Thursday 5 th November 2015 BOARDROOM A, BECKETTS HOUSE, ILFORD, IG1 2QX PRESENT Dr G Kalkat (GK) Oge Chesa (OC) Belinda Krishek (BK) Dr C Okorie (CO) Dr K Kugathas
More informationCroydon Clinical Commissioning Group Clinical Leadership Meeting Minutes
Attachment 16 Appendix 1 Date: 13 July 2012 Time: 13 30 15 30 Location: Room 11.4, Leon House Present: Dev Malhotra, GP Board Member Bobby Abbot, GP Dipti Gandhi, Clinical Leader Brian Okumu, GP Clinical
More informationQuality and Patient Safety Report. Board Meeting. 17 October 2011
Quality and Patient Safety Report Board Meeting 17 October 2011 Author(s)/Presenter and title Sponsor Director Purpose of Paper Patient Safety/Quality Leads South Yorkshire and Bassetlaw Margaret Kitching,
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12. Date of Meeting: 23 rd March 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 12 Date of Meeting: 23 rd March 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationMANAGING THE INR CLINIC : IJN EXPERIENCE
MANAGING THE INR CLINIC : IJN EXPERIENCE Anticoagulation Workshop 21 st August 2015 KAMALESWARY ARUMUGAM PRINCIPAL PHARMACIST LEE LEE HO1 NURSE MENTOR, INR CLINIC HISTORY & OVERVIEW OF THE INR CLINIC HISTORY
More informationImproving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
More informationCroydon Health Services NHS Trust (Working in Partnership) Shared Care Guideline: Prescribing Agreement
Shared Care Guideline: Prescribing Agreement Section A: To be completed by the hospital consultant initiating the treatment GP Practice Details: Name: Address: Tel no: Fax no: NHS.net e-mail: Consultant
More informationJennifer Riley, Senior Commissioning Manager. Barry Silvert, Clinical Director Commissioning
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 7 Date of Meeting: 24 th June TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives) Pain
More informationMedicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
More informationBromley CCG Quality Framework: Procurement/ Contracting/ Contract monitoring Nov 2014
Bromley CCG Quality Framework: Procurement/ Contracting/ Contract monitoring Nov 2014 This framework has been developed within the Quality, Patient Safety and Governance directorate to support staff working
More informationGuidelines for Repeat Prescribing by General Practitioners
Guidelines for Repeat Prescribing by General Practitioners Version: Ratified by: Final PCT Professional Executive Committee Date ratified: 7 th April 2009 Lead Executive/Director: Name of originator/author:
More informationClinical Check of Prescriptions in Ward Areas
Pharmacy Department Standard Operating Procedures SOP Title Clinical Check of Prescriptions in Ward Areas Author name and Gareth Price designation: Deputy Director of Pharmacy Clinical Services Pharmacy
More informationThe safety of every patient we care for is our number one priority
HUMBER NHS FOUNDATION TRUST INFECTION PREVENTION AND CONTROL STRATEGY 2015-2017 1. Introduction Healthcare associated infections (HCAI) continue to be a major cause of patient harm and although nationally
More informationMINUTES MERTON CLINICAL COMMISIONING GROUP GOVERNING BODY PART 1 18 th April The Broadway, Wimbledon, SW19 1RH
MINUTES MERTON CLINICAL COMMISIONING GROUP GOVERNING BODY PART 1 18 th April 2018 120 The Broadway, Wimbledon, SW19 1RH Chair: Dr Andrew Murray In attendance: Members SB Sarah Blow Accountable Officer
More informationPrescribing and Administration of Medication Procedure
Prescribing and Administration of Medication Procedure Version: 3.3 Bodies consulted: - Approved by: PASC Date Approved: 1.4.16 Lead Manager Lead Director: Head of Child and Adolescent psychiatry Medical
More informationSFHPHARM27 - SQA Unit Code FA2P 04 Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check
Undertake an in-process accuracy check of assembled prescribed items prior to the final accuracy check Overview This standard describes the skills, knowledge and understanding required to demonstrate competence
More informationPGDs are permitted for use only by registered health professionals (see enclosed link for full list
NHS England North - Yorkshire and the Humber Region Protocol for the Development, Authorisation and Use of Patient Group Directions for the National Immunisation Programmes 1. Introduction The preferred
More informationStrategic overview: NHS system
Strategic overview: NHS system Dr Keith Ridge, Chief Pharmaceutical Officer 1 November 2016 A collaborative approach Five Year Forward View Oct 2014 NHS planning guidance, Dec 2015: Every health and care
More informationCLINICAL GOVERNANCE AND QUALITY COMMITTEE. Final - Terms of Reference - Final
CLINICAL GOVERNANCE AND QUALITY COMMITTEE Final - Terms of Reference - Final CONSTITUTION 1. The Board of Directors approved the establishment of the Clinical Governance and Quality Committee (known as
More informationQUALITY IMPROVEMENT COMMITTEE
: 2016-002.a QUALITY IMPROVEMENT COMMITTEE Minutes of the meeting held on 11 th February 2016, Conference Room D, 1829 Building Present: Faulkner, Sarah (SF) (Chair) Lay Member, NHS West Cheshire CCG Cavanagh,
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationPharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02
Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 V02 issued Issue 1 May 11 Issue 2 Dec 11 Planned review May
More informationNHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 14. Date of Meeting: 29 th June 2018 TITLE OF REPORT:
NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 14 Date of Meeting: 29 th June 2018 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)
More informationRegional Medicines Optimisation Committees
Regional Medicines Optimisation Committees Operating Model First Edition, April 2017 NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans.
More informationPolicy Document Control Page
Policy Document Control Page Title Title: Safe Management of Controlled Drugs Policy Version: Version 7 Reference Number: CL44 Supersedes: Version 6.1 Description of amendment(s) Section. Update of definitions
More informationAll areas of the Trust All Trust staff All Patients Deputy Chief Nurse & Chief Pharmacist Final
Trust Policy and Procedure Document Ref. No: PP(15)233 Non-Medical Prescribing Policy For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff All Patients Deputy
More informationNHS DORSET CLINICAL COMMISSIONING GROUP PRIMARY CARE COMMISSIONING COMMITTEE MEDICINES MANAGEMENT REPORT. The Committee is asked to note the report.
NHS DORSET CLINICAL COMMISSIONING GROUP 7.4 PRIMARY CARE COMMISSIONING COMMITTEE MEDICINES MANAGEMENT REPORT Date of the meeting 03/10/2018 Author Purpose of Report Recommendation Stakeholder Engagement
More informationAudit Data Collection Form
pecialist Pharmacy ervice Medicines Use and afety Audit Data Collection Form Collaborative audit across England on the quality of medication related information provided when transferring patients from
More informationCommunity Pharmacy Intervention Scheme
Aim Community Pharmacy Intervention Scheme To utilise community pharmacy to support costeffective prescribing and achievement of the HSCB Medicines Management Strategy through identification of specific
More informationDelivering the QIPP programme: making existing services improve patient outcomes
Delivering the QIPP programme: making existing services improve patient outcomes Produced by Glyn Davies MP, Chair All-Party Parliamentary Group on AF in association with the Atrial Fibrillation Association
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationBest Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
More informationQuality Assurance Framework. Powys thb provided and commissioned services Quality and Safety Committee November 2013
Quality Assurance Framework Powys thb provided and commissioned services Quality and Safety Committee November 2013 1 Background Together for Health vision for NHS Wales 6 domains of quality Effectiveness
More informationPrimary Care Prescribing Cardiff and Vale University Health Board. Issued: December 2013 Document reference: 447A2013
Primary Care Prescribing Cardiff and Vale University Health Board Issued: December 2013 Document reference: 447A2013 Status of report This document has been prepared for the internal use of Cardiff and
More informationMinutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting pm, Wednesday 15 May 2013 Room GO2-A, 160 Tooley Street
Minutes of the Lambeth and Southwark Joint Prescribing Committee (JPC) meeting 2. 00 pm, Wednesday 15 May 2013 Room GO2-A, 160 Tooley Street Present: Dr Catherine Otty (CO) Dr Alan Campion Dr Sian Howell
More informationDocument Details. Patient Group Direction
Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain
More information